Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Jungle Ventures leads $20 mn Series B round in RED.Health
Medical emergency response platform RED.Health, which claims to dispatch ambulances within eight minutes, has raised $20......
Healthcare
Mahindra's PE arm exits healthcare firm as new investor comes on board
Mahindra Partners, the private equity arm of diversified Mahindra Group, has got a complete exit from a five-year-old ......
Healthcare
Biorad brings new PE investor on board after giving exit to InvAscent
Medical devices maker Biorad Medisys Pvt Ltd, which was backed by healthcare-focused private equity firm InvAscent, ......
Healthcare
Spotlight: Ascent-backed Skanray needs to defy one-trick-pony act to get new investors
Mysore-based medical device manufacturer Skanray Technologies Pvt. Ltd recorded robust growth during FY21 amid a raging ......
Healthcare
ChrysCap makes a liquidity move with benchmark returns
Indian private equity firm ChrysCapital, which was recently trumped by Kedaara Capital in raising the largest India-......
Healthcare
How did Investcorp's latest India exit move pan out?
Bahrain-based alternative asset manager Investcorp has made its second India exit move of 2024, adding to its harvests ......
Healthcare
Kelix Bio to acquire five UAE-based pharma entities post Mubadala deal
Kelix Bio, an emerging markets-focused specialty generic biopharmaceutical company is looking to acquire five UAE-based ......
Healthcare
Warburg, Carlyle, others in fray for stake in healthcare tech solutions provider
A string of global buyout firms including Thoma Bravo, CVC Capital, Carlyle, Platinum Equity and Warburg Pincus are ......
Healthcare
CK Birla Group's IVF arm marks fresh acquisition in bid to expand
Infertility hospital Birla Fertility & IVF, part of the $2.9 billion CK Birla Group, on Wednesday said it has acquired ......
Healthcare
Kedaara Capital makes a quiet exit. Did it make any money?
Private equity firm Kedaara Capital has sold its entire stake in a pharmaceutical company, marking an exit from its ......